Skip to main content
. 2021 Nov 9;12(5):2550–2567. doi: 10.1016/j.apsb.2021.11.004

Scheme 1.

Scheme 1

Schematic illustration of NGP@MI used for chemo-immunotherapy. (A) The preparation process of NGP@MI. (B) The biodistribution, pH-triggered drug release and mechanism of NGP@MI for combinational treatment of chemotherapy and immunotherapy against TNBC.